Press Releases

TissueTech Grows Sales Force to Support Footprint Expansion

Demand for minimally invasive surgical procedures results in service expansion into Ohio, Texas, Michigan, New York, and New Jersey Miami, FL – October 13, 2021 – TissueTech, Inc., a pioneer in the clinical application of cryopreserved human birth tissue allografts to treat ocular surface disease and disorders, chronic wounds, and musculoskeletal conditions, announced today that […]

Bio-Tissue, Inc. Signs National Agreement with EyePro GPO to Afford Members Exclusive Treatment Options for Ocular Surface Disease and Disorders

Bio-Tissue

Group Purchasing Organization members now have streamlined access to Bio-Tissue’s complete product portfolio to facilitate regenerative healing and help normalize the ocular surface quickly as an essential part of the pre-cataract surgical regimen Miami, FL – October 12, 2021 – Bio-Tissue, Inc., a TissueTech company and pioneer in the clinical application of human birth tissue […]

Inaugural Leadership Summit brings together Key Opinion Leaders from Across the Clinical Spectrum to Share Best Practices on Regenerative Medicine

TissueTech, Inc., a pioneer in the clinical application of cryopreserved amniotic membrane birth tissue allografts, announced today that the company had completed its first physician leadership summit.

Amniox Launches New Complex Wound Management Campaign in Support of Wound Healing Awareness Month

Amniox Medical

The Amniox Advantage campaign explores Amniox’s platform technology that has set the standard in successfully treating complex and non-healing wounds Miami, FL – June 10, 2021 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue products, is launching a new awareness campaign that showcases the […]

Amniox Awarded National Agreements with Premier, Inc. and The Resource Group for Birth Tissue Skin Grafting Products

Amniox Medical

Agreements afford more than 200,000 group purchasing organization members with scaled purchasing options for cryopreserved amniotic membrane and umbilical cord birth tissue products Miami, FL – May 11, 2021 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that its parent company […]

Bio-Tissue to Present Webinar in 3-D Showcasing New Treatment Regimen to Successfully Diagnose and Treat Mechanical Dry Eye

Bio-Tissue

In conjunction with National Mechanical Dry Eye Day on May 19, 2021, Neel Desai, M.D. will host a special webinar to raise awareness about the management of Mechanical Dry Eye Miami, FL – May 10, 2020 – Bio-Tissue, Inc., a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue products, announced […]

TissueTech Partners with Donate Life America to Raise Public Awareness about the Importance of Tissue Donation

Leader in regenerative medicine joins forces with advocates to spread awareness on the role tissue donation can play in restoring quality of life and improved health Miami, FL – April 19, 2021 – TissueTech, Inc., a pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today that it […]

TissueTech Receives FDA Clearance to Proceed with Phase 1 Clinical Study using Investigational New Drug TTAX03 to Treat Facet Joint Osteoarthritis Pain

Amniox Medical

Investigators will evaluate the dosage and safety of Cryopreserved Amniotic Membrane and Cryopreserved Umbilical Cord TTAX03 for pain relief and functional improvement of facet joint osteoarthritis in the lumbosacral region Miami, FL – March 8, 2021 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based […]

TissueTech Receives U.S. Food and Drug Administration Clearance to Proceed with Clinical Study using Investigational New Drug TTBT01

Bio-Tissue

Regenerative medicine research pioneer takes the first step towards commercializing human birth tissue-based biologic products for the treatment of ocular surface disease and disorders Miami, FL – March 1, 2021 – Bio-Tissue, Inc., a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that its parent company TissueTech […]

Bio-Tissue Expands Health Plan Geographic Footprint in Pennsylvania for Reimbursement Coverage of PROKERA Biologic Corneal Bandage

Bio-Tissue

Highmark Blue Cross Blue Shield joins the ranks of the more than 90 percent of commercial health plans who already offer reimbursement coverage for PROKERA Cryopreserved Amniotic Membrane Miami, FL – February 17, 2021 – Bio-Tissue, Inc., a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that […]

Archives

  • 2021
  • 2020
  • 2019
  • 2018